A Guide to Female Sexual Dysfunction Treatments
It is not approved for women past
- Filbanserin (Addyi) is not available on the standard NHS drug tariff.
- Vyleesi (Bremelanotide) is also not routinely funded by the NHS in the UK.
- Ospemifene (Senshio) may be prescribed on the NHS for specific menopausal symptoms.
- Testosterone is used off-label, and funding can vary by local Clinical Commissioning Group.
- Most treatments for FSD are primarily accessed through private prescription.
- Private consultation costs range from £50-£250, plus the cost of medication.
- Some private health insurance policies may cover specialist consultations and treatments.
the menopause or anyone with an impaired liver. It can cause low blood pressure and loss of consciousness.
The #1 Prescribed Treatment for frustrating Low Libido1
"As a sexual health expert, as a gynaecologist, as someone who takes care of women every single day, this is going to be a game changer for me because right now I have women that come into my office and have a distressing lack of sexual desire and I just say, 'I'm so sorry. There is nothing that I can do.'" A free daily email with the biggest news stories of the day – and the best features from TheWeek.com But critics argue that the drug is simply not effective enough. According to FDA analysis, only between 8 and 13 percent of women who take the pill will see some improvement. "That's a pretty small number, particularly when you consider how "improvement" has been defined," says Vox. Women taking the pill have on average just 0.5 more "sexually satisfying events" per month.
What causes low libido in women?
Dr. Adriane Fugh-Berman from Georgetown University has described the drug as "a mediocre aphrodisiac with scary side effects". These include very low blood pressure, dizziness, sleepiness and even loss of consciousness. Drinking alcohol and taking some forms of birth control will increase the risk of the side-effects. Evidence of the drug's safety and efficacy has not improved since it was last rejected, and many have suggested that the FDA approval was a result of a sustained lobbying campaign by drug makers.
What are other tips for boosting female sex drive?
Sprout Pharmaceuticals helped launch a public relations campaign called "Even the Score" which accused the FDA of sexism for only having ever approved drugs to treat male sexual dysfunction. "The FDA has turned this down twice before, and now we have no new evidence of benefits, and we have more evidence of harms, so if the FDA does approve the drug today the only thing that changed is the amount of pressure put on it by a corporation though a major PR campaign," said Fugh-Berman. Amy Allina, deputy director of the National Women’s Health Network said that while she agrees with the pharmaceutical company that women deserve to have their sexual problems taken seriously – "we do not believe that a minimally effective drug that must be taken daily, causes significant side effects and has not been evaluated for long-term safety, offers women a serious solution." It is the small pink pill that its manufacturers hope will do for women what Viagra did for men. The decision to give the drug a marketing licence in the US has been cheered on by campaigners for women’s rights, but the question remains whether Addyi is the breakthrough medicine claimed. Men have the blue diamond-shaped Viagra pill and 25 others (although 17 of those are forms of testosterone), while there has until now been no counterpart for women. Those risks are higher if women drink.
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Viagra Generic | 50mg | 90 + 6 Pills | 107.37€ 102.26€ | |
| Viagra Generic | 100mg | 180 + 8 Pills | 199.37€ 189.88€ | |
| Viagra Generic | 25mg | 30 + 4 Pills | 47.97€ 45.69€ | |
| Viagra Generic | 100mg | 120 + 6 Pills | 149.50€ 142.38€ | |
| Viagra Generic | 25mg | 180 + 6 Pills | 154.93€ 147.55€ | |
| Viagra Generic | 150mg | 180 + 10 Pills | 236.46€ 225.20€ | |
| Viagra Professional | 100mg | 90 + 2 Pills | 207.09€ 197.23€ | |
| Viagra Generic | 150mg | 360 + 10 Pills | 423.48€ 403.31€ | |
| Viagra Generic | 25mg | 20 Pills | 37.74€ 35.94€ | |
| Viagra Professional | 100mg | 360 + 6 Pills | 527.09€ 501.99€ | |
| Viagra Generic | 200mg | 60 + 4 Pills | 125.19€ 119.23€ | |
| Viagra Generic | 25mg | 270 + 8 Pills | 184.26€ 175.49€ | |
| Viagra Professional | 100mg | 30 Pills | 88.92€ 84.69€ | |
| Viagra Super Active | 100mg | 30 + 6 Pills | 64.09€ 61.04€ | |
| Viagra Generic | 50mg | 60 + 4 Pills | 83.93€ 79.93€ | |
| Viagra Soft Tabs | 100mg | 120 + 8 Pills | 232.21€ 221.15€ | |
| Viagra Soft Tabs | 100mg | 60 + 6 Pills | 152.94€ 145.66€ |
“Because of a potentially
MEET OUR LOW LIBIDO TREATMENT
But sex and relationship therapists say Addyi is only moderately effective, should not be taken with alcohol, and has potentially serious side-effects. Trials showed that Addyi gave women who took it daily one extra sexually satisfying experience per month. Some of the women who testified before the US drug licensing committee, the Food and Drug Administration, seemed to believe the pill would bring back the passion and romance of times past, but there are fears they are being sold an unfulfillable dream. “I am concerned about the expectations that women have,” said Cynthia Graham, professor in sexual and reproductive health at the University of Southampton. “Among women who spoke at the FDA, there were expectations that you can have sexual desire that is at a high level and nothing is going to affect it – that it will be right back where it was when you met your partner.” Graham and other critics believe the FDA was pressured and half-shamed into approving strongest viagra pill Addyi (generic name flibanserin) by a campaign headed by a vocal group called Even the Score, which pitched the absence of drugs to help women with low libido as a gender inequality issue.
Vyleesi (bremelanotide)
It describes itself as a campaign for women’s sexual health equality which was “created to serve as a voice for American women who believe that it’s time to level the playing field when it comes viagra online generic to the treatment of women’s sexual dysfunction”. On the front page of its website now runs a banner saying “Thank you, FDA”. Sprout Pharmaceuticals, which owns Addyi, is one of the funders, as is Trimel, another company in the same field. Its shareholders should be in for a windfall if the drug produces even a fraction of the success and profits Viagra did for Pfizer. Sprout’s chief executive, however, hailed the FDA decision as a victory for women.
CONVENIENT & DISCREET
“It has been a remarkable journey to get to this breakthrough moment. Today we celebrate what this approval means for all women who have long awaited a medical treatment option for this life impacting condition,” said Cindy Whitehead. “We applaud the FDA for putting the patient voice at the center of the conversation and for focusing on scientific evidence.” The drug, an antidepressant that works on the brain, unlike Viagra, was rejected twice by the FDA on the basis of a small benefit and substantial side-effects. The final vote was 18 to 6, with none of the panel willing to endorse it without caveats. Addyi will have a black box warning, meaning there are serious side-effects. serious interaction with alcohol, treatment
- The topic is often sensationalized in media as a search for a "pink Viagra."
- This can create unrealistic expectations about a simple pill solving complex issues.
- Ethical debates concern medicalizing normal variations in female sexual desire.
- The high cost of new drugs creates issues of accessibility and healthcare inequality.
- Off-label use of testosterone is common but lacks long-term safety data for women.
- The primary focus should be on treating the underlying cause, not just the symptom.
- Patient education and managing expectations are a critical part of the process.
with Addyi will only be available through certified health
- There is no true over-the-counter "female Viagra" available in UK pharmacies.
- Viagra (sildenafil) is licensed for men and is not approved for female sexual dysfunction.
- Some online sources may illegally sell prescription-only medications without consultation.
- Herbal libido supplements are available OTC but are not proven to be effective.
- Lubricants and moisturizers are widely available OTC without a prescription.
- Buying prescription medicine without a prescription is illegal and potentially dangerous.
- Always obtain medications through a legitimate consultation with a qualified prescriber.
care professionals and certified
| Attitude Aspect | Description | Key Influencers |
|---|---|---|
| Public acceptance | Increasing acceptance of female sexual health products | Media campaigns, education efforts |
| Medical professional perspectives | Growing support but some hesitance | Doctors, sexologists |
| Social stigma | Lessening but still present in some communities | Cultural shifts |
pharmacies,” said Dr Janet Woodcock,
The Sexy Science Behind Dare to Play
An earlier study across the pond showed that 75% of women would rather not discuss the subject as they thought the doctor would not be interested. There is only one FSD drug available in the UK, where over 10 million women are thought to suffer from sexual dysfunction in their lifetime. That is Procter & Gamble’s Intrinsa, a testosterone skin patch which is given to women who have had their uterus and/or ovaries removed. New therapies are on the way, however, some of which target the psychological aspect of FSD, including Boehringer Ingelheim’s flibanserin, an oral pill originally developed as an antidepressant. However, Ms Marescotti notes that “those hoping for a ‘female Viagra’ will be disappointed.
Interactions with other medications
In contrast to erectile dysfunction, she adds that “the complicated nature of FSD means that a quick fix in the form of an effective pill is very hard to achieve”. Flibanserin has finally been approved by the US drugs agency – but only after two unsuccessful attempts The first drug to treat a lack of sexual desire in women has been approved by the US Food and Drug Administration, but it continues to divide medical professionals. "Today's approval provides women distressed by their low sexual desire with an cialis or viagra for women approved treatment option," said Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research. But Flibanserin has already been rejected twice by the drugs agency and there are widespread concerns about the safety and efficacy of the much-anticipated pill nicknamed the "female Viagra". From our daily WeekDay news briefing to an award-winning Food & Drink email, get the best of The Week delivered directly to your inbox.
Side effects
What is it and how does it work? The drug, sold under the brand name Addyi and produced by Sprout Pharmaceuticals, is designed to treat low libido in premenopausal women. One small pink pill is taken daily by women who have been diagnosed with Hypoactive Sexual Desire Disorder. Unlike Viagra, the drug does not relax muscles or increase blood flow, but changes brain chemistry similar to the way that antidepressants do, The Guardian reports. Dr Lauren Streicher of Northwestern University told NBC News that the FDA approval is a "huge advancement" in women's health. director of the FDA’s Center
| Condition | Description | Typical Treatment Approach | Alternative Options |
|---|---|---|---|
| Hypoactive Sexual Desire Disorder | Low sexual desire in women | Medication, counseling | Therapy, lifestyle changes |
| Postmenopause Libido Loss | Reduced libido after menopause | Hormone therapy, medications | Vaginal lubricants, counseling |
| Sexual Arousal Disorder | Difficulty achieving arousal | Available medications | Relaxation techniques |
for Drug Evaluation and Research.
Interested, but not quite ready?
What Is the Female Version of Viagra Called?The FDA approved two versions of female Viagra to treat female sexual dysfunction, which are called flibanserin (Addyi) and bremelanotide. What Is the Main Cause of Erectile Dysfunction?Penile erection is a complex process in which the brain, nerves, muscles and blood vessels play a major role. The main causes of erectile dysfunction include psychological and health conditions,.. Yohimbine has also been used as a street drug,.. Yahoo is part of the Yahoo family of brands.
Exploratory Phase 2b RESPOND Study, Completed in 2023
provide our sites and apps to you authenticate users, apply security measures, and prevent spam and abuse, and measure your use of our sites and apps , including 247 who are part of the IAB Transparency & Consent Framework, will also store and / or access information on a device (in other words, use cookies) and use precise geolocation data and other personal data such as and browsing and search data, for analytics, personalised advertising and content, advertising and content measurement, and audience research and services development. If you do not want us and our partners to use cookies and personal data for these additional purposes, click 'Reject all'. If you would like to customise your choices, click 'Manage privacy settings'. Society and cultural barriers will continue to prevent women from recognising that they may suffer from female sexual dysfunction and seeking help, according to a new report. Furthermore, the analysis, published by Datamonitor, notes that the non life-threatening nature of the disorders means that FSD “is often disregarded by the medical community”.
CUSTOM FORMULATED
FSD is an umbrella term that covers a variety of different dproblems from hypoactive sexual desire disorder (or low libido) and sexual arousal disorder to painful intercourse. Also there is often an overlap between disorders that can affect diagnosis and treatment. Maya Marescotti, women’s health analyst at Datamonitor, says there is “a stigma associated with talking about sex, cultural embarrassment, and avoidance of discussion of sexual dysfunction in the clinical environment”. She adds that “these are common barriers that prevent doctors and patients from talking about sex”. In a recent US study of 198 healthcare providers, only 34% of physicians would discuss sexual health with their patients on their own initiative.